Basic Information
Cellbricks Therapeutics is a tissue engineering company dedicated to developing biomanufactured human tissue implants for regenerative medicine. The company utilizes its proprietary biomanufacturing platform to design vascularized human tissue therapies aimed at restoring function in patients with severe tissue damage, including complex wounds and soft tissue defects, with potential applications in long-term organ repair and replacement.
Cellbricks GmbH
Berlin,Berlin,Germany
15~50 people
January 01, 2016
info[at]cellbricks.com

